|
Market Cap (24-Jun) $646,684,416 (796th) |
Close (30-Jun) $0.330 |
Volume (30-Jun) 147,149 |
Shortsold (26-May) 152,126 (0.04%) (509th) |
|
52w High $2.25 |
52w Low $1.15 |
P/E - |
EPS -0.11 |
IMR released this announcement to the ASX on 24 January 2023, 9:21. The announcement is marked as price sensitive, and is 3 page(s) in length and 300.74kb in size.
You can view all announcements from IMR and see how they appear on a price chart on the announcements page.
At the date of this announcement, IMR was 0.082% short sold according to ASIC data. It was ranked the 477th most shorted stock on the ASX. It remains ranked 509th as of the latest reported data (26 May 2026).
| Other Recent Announcements from IMR | |
|---|---|
| Notification of cessation of securities - IMR | 9 June 2023, 11:34 |
| Appendix 3Y - SW | 7 June 2023, 11:12 |
| Notification regarding unquoted securities - IMR | 6 June 2023, 9:36 |
| Imricor Receives IDE Approval from US FDA | 24 January 2023, 9:21 |
| Imricor Q4 FY22 Quarterley Activities Report and Appendix 4C | 20 January 2023, 9:27 |
| Notification of cessation of securities - IMR | 13 January 2023, 12:46 |
| Notification regarding unquoted securities - IMR | 3 January 2023, 9:21 |
You must be logged in to post a reply.
Imricor Medical Systems, Inc 